Sequana Medical NV SEQUA-BE:Euronext Brussels

*Data is delayed | EUR
Last | 03/05/21 CET
8.00quote price arrow down-0.30 (-3.61%)
Volume
22,838
52 week range
4.60 - 12.40

...

Loading . . .

KEY STATS

  • Open8.30
  • Day High8.30
  • Day Low8.00
  • Prev Close8.30
  • 52 Week High12.40
  • 52 Week High Date01/04/21
  • 52 Week Low4.60
  • 52 Week Low Date03/18/20
  • Market Cap150.81M
  • Shares Out15.78M
  • 10 Day Average Volume28,508.64
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • 1 Year % Change21.58

RATIOS/PROFITABILITY

  • EPS (TTM)-1.23
  • P/E (TTM)-6.51
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sequana Medical NV News

There is no recent news for this security.

Latest SEQUA-BE News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant...
Pierre Chauvineau
Non-Executive Chairman
Ian Crosbie
Chief Executive Officer
Kirsten Van Bockstaele
Chief Financial Officer
Dirk Fengels
Vice President
Timur Resch
Vice President
Address
Technologiepark 122, Zwijnaarde
Gent
9052
Belgium